Back to all news
AI Model Improves Differentiation of Brain Tumor Progression from Radiation Necrosis on MRI
A York University-led study shows a novel AI using advanced MRI can distinguish between progressive brain tumors and radiation necrosis more accurately than human assessment.
Key Details
- 1AI model uses attention-guided deep learning with chemical exchange saturation transfer (CEST) MRI.
- 2Study included over 90 patients with brain metastases treated by stereotactic radiosurgery (SRS).
- 3AI achieved over 85% accuracy in distinguishing tumor progression from necrosis, compared to ~60% for standard MRI and ~70% for advanced MRI alone.
- 4Published December 2025 in International Journal of Radiation Oncology, Biology, Physics.
- 5A crucial clinical challenge as treatment decisions for tumor progression vs necrosis are substantially different.
Why It Matters
Differentiating tumor progression from radiation necrosis on MRI post-therapy is a major clinical challenge, as each requires different treatments. AI that improves diagnosis accuracy could substantially impact patient management and outcomes in neuro-oncology.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.